Australia, May 5 -- SPIKIMM, owns the trademark (2622808) for 'SPIKIMM' till Oct. 14, 2035.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical products; monoclonal antibodies for medical, pharmaceutical and therapeutic use; chemical and biological preparations, for therapeutic, medical, pharmaceutical use; diagnostic preparations for therapeutic and medical use; chemical reagents for medical use; reagents for development of monoclonal antibodies for medical use.] and 42 [Scientific research for medical purposes; biological research; biochemical research; research and development services for pharmaceutical preparations; conducting clinical trials; clinical research; conducting scientific studies and analyses; biological, biotechnological, biochemical, medical and pharmaceutical research and development services for third parties; evaluation of the efficacy of pharmaceutical products.]
Type of Mark: Word
Date of Acceptance: Feb. 24
Registration Advertised: May 4
For further details contact Halfords IP and Madame TERTRAIS Marion IPSILON.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2622808.
Disclaimer: Curated by HT Syndication.
